On January 24, 2024, Daniel Menold ceased to be the principal accounting officer of CymaBay and Harish Shantharam became the principal accounting officer in addition to his role as principal financial officer and Chief Financial Officer.
Effective January 25, 2024, the Board appointed Kostas Dafoulas to serve as the Company’s interim Chief Financial Officer following the retirement of Mr. James.
On January 23, 2024, Lisa Walters-Hoffert informed Daré Bioscience, Inc. (“our,” “we”, “us,” “our,” or the “Company”) that she will retire from all positions with the Company, and her employment with the Company will end, effective January 26, 2024.
On January 23, 2024 Shufang Gao resigned from his position as the Registrant’s Chief Financial Officer.
Appointed
Zack Malkin
Chief Financial Officer
Rain Oncology Inc.
Effective
2024-01-26
Filed
January 26, 2024, 6:59 PM ET
The executive officers of Merger Sub immediately prior to the Effective Time were Ryan Fukushima, serving as Chief Executive Officer, and Zack Malkin, serving as Chief Financial Officer and Secretary.
Appointed
Ryan Fukushima
Chief Executive Officer
Rain Oncology Inc.
Effective
2024-01-26
Filed
January 26, 2024, 6:59 PM ET
The executive officers of Merger Sub immediately prior to the Effective Time were Ryan Fukushima, serving as Chief Executive Officer, and Zack Malkin, serving as Chief Financial Officer and Secretary.
Appointed
Richard C. Puccio, Jr.
Executive Vice President and Chief Financial Officer
On January 25 , 2024, Analog Devices, Inc. (the “Company”) announced the appointment of Richard C. Puccio, Jr. as Executive Vice President and Chief Financial Officer (principal financial officer), effective as of February 5, 2024.
On January 23, 2024, upon Mr. Martin’s appointment as the Company’s Chief Financial Officer, Kenneth S. Booth, the Company’s Chief Executive Officer, ceased to serve as the Company’s principal financial officer.
On January 23, 2024, effective on such date, the board of directors (the “Board”) of Credit Acceptance Corporation (referred to as the “Company,” “Credit Acceptance,” “we,” “our” or “us”) appointed Jay D. Martin, who had been serving as our Senior Vice President, Finance and Accounting and, as such, our principal accounting officer, as the Company’s Chief Financial Officer.
Appointed
(interim)
Uzi Sasson
Principal Financial Officer
META MATERIALS INC.
Effective
2024-01-22
Filed
January 25, 2024, 6:59 PM ET
on January 22, 2024, the Board appointed Mr. Sasson to act as the principal financial officer of the Company for SEC reporting purposes, and he will serve in such role until a new principal financial officer is appointed by the Company.
Effective January 29, 2024, Eddie Ni, who currently serves as Chief Executive Officer of the Registrant and a member of the Board of Directors, was appointed to serve as Chief Financial Officer as well.
On January 24, 2024, Ray Chen, Chief Financial Officer of Goldenstone Acquisition Limited (the “Registrant”) resigned his position as Chief Financial Officer with such resignation to be effective as of January 29, 2024.
Appointed
Teresa Gallo
Chief Executive Officer
NYIAX, INC.
Effective
2024-01-19
Filed
January 25, 2024, 6:59 PM ET
On January 19, 2024, the Board of Directors (the “Board”) of the Company appointed Teresa Gallo as the Chief Executive Officer (the “CEO”) of the Company.
On January 24, 2024, the Board of Directors (the “Board”) of CPI Card Group Inc. (the “Company”) appointed John Lowe, who currently serves as Executive Vice President, End-to-End Payment Solutions, as President and Chief Executive Officer of the Company, effective January 25, 2024.
At that time, Jeffery T. Mezger, KB Home’s president and chief executive officer since 2006 and chairman since 2016, will become chairman and chief executive officer.
Appointed
Michael Bourque
Executive Vice President, Chief Financial Officer and Treasurer
On January 21, 2024, the Board of Directors (“Board”) of Inogen, Inc. (the “Company”) appointed Michael Bourque to serve as Executive Vice President, Chief Financial Officer and Treasurer (“CFO”) of the Company, effective March 4, 2024.
Role change
Chandan Basho
Chief Financial Officer and Chief Operating Officer
In connection with the re-appointment of Mr. Curelaru as the Company’s Chief Financial Officer, Mr. Brock resigned as Interim Chief Financial Officer of the Company, on and effective January 22, 2024.
On January 22, 2024, Mr. Curelaru was re-appointed as the Company’s Chief Financial Officer of the Company, effective immediately.
Departed
Ellen Harrison
Chief Executive Officer
MedMen Enterprises, Inc.
Effective
2024-01-19
Filed
January 24, 2024, 6:59 PM ET
On January 19, 2024, Ellen Harrison notified the board of directors (the “Board”) of MedMen Enterprises Inc. (the “Company”) of her resignation from her positions as the Company’s Chief Executive Officer and as a member of the Board, effective immediately.
Appointed
Derek Shelnutt
Executive Vice President and Chief Financial Officer
On January 18, 2024, Colony Bankcorp, Inc. (the “Company”), named Mr. Derek Shelnutt, the current Chief Accounting Officer of the Company and Chief Financial Officer of Colony Bank (the “Bank”), as Executive Vice President and Chief Financial Officer of the Company effective January 23, 2024.
On January 23, 2024, the Company announced it would appoint Eric Rivera, currently the Company’s vice president, chief accounting officer and corporate controller, to the role of interim chief financial officer of the Company, effective February 23, 2024 upon Mr. Jordan’s retirement.
the Board of Directors of Duluth Holdings Inc. (the “Company”) appointed Heena Agrawal as Senior Vice President and Chief Financial Officer of the Company, effective February 12, 2024.
Effective February 12, 2024, Mr. Murphy will step down from his role as Interim Chief Financial Officer and will continue in his role as VP, Chief Accounting Officer and will assume responsibility for the Company’s treasury function
The Company has also announced that Brian Markison, the Chairman of the Board, has been appointed Executive Chairman as of January 23, 2024 to serve in that role until the Effective Date and will become the Company’s Chief Executive Officer effective on the Effective Date.
Mary Anne Heino, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), notified the Board on January 18, 2024, of her intention to retire as Chief Executive Officer, effective March 1, 2024
Appointed
Thomas L. Monahan III
Chief Executive Officer
HEIDRICK & STRUGGLES INTERNATIONAL INC
Effective
2024-03-04
Filed
January 23, 2024, 6:59 PM ET
On January 23, 2024, the Company announced that the Board appointed Thomas L. Monahan III to serve as the Chief Executive Officer of the Company and, following the recommendation of the Nominating and Board Governance Committee of the Board, appointed Mr. Monahan to serve as a member of the Board, each effective as of the Transition Date.
Departed
Krishnan Rajagopalan
President and Chief Executive Officer
HEIDRICK & STRUGGLES INTERNATIONAL INC
Effective
2024-03-04
Successor
Thomas L. Monahan III
Filed
January 23, 2024, 6:59 PM ET
On January 23, 2024, Krishnan Rajagopalan, the President and Chief Executive Officer of the Company, notified the Board of Directors (the “Board”) of the Company of his decision to step down as the Company’s President and Chief Executive Officer on March 4, 2024 (the “Transition Date”) and retire from the Company on April 1, 2024.
Departed
Amy Reeves
Chief Financial Officer
View, Inc.
Effective
2024-02-02
Filed
January 23, 2024, 6:59 PM ET
On January 17, 2024, View, Inc. (the “Company”) was informed by Amy Reeves, the Company’s Chief Financial Officer, that she will resign from such position effective February 2, 2024.
Departed
John Koconis
Chief Executive Officer, President and Chairman of the Board
TREX WIND-DOWN, INC.
Effective
2024-01-22
Filed
January 23, 2024, 6:59 PM ET
Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company’s subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.
Departed
Joseph Lucchese
Chief Financial Officer, Treasurer and Secretary
TREX WIND-DOWN, INC.
Effective
2024-01-22
Filed
January 23, 2024, 6:59 PM ET
Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company’s subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.
Departed
Nathan Haas
Chief Financial Officer
Vitro Biopharma, Inc.
Effective
2024-01-18
Successor
Thomas W. Ohrt
Filed
January 23, 2024, 6:59 PM ET
Pursuant to the Settlement Agreement, the parties confirmed Mr. Haas’s resignation as Chief Financial Officer, effective January 18, 2024.
Appointed
Thomas W. Ohrt
Chief Financial Officer
Vitro Biopharma, Inc.
Effective
2024-01-22
Filed
January 23, 2024, 6:59 PM ET
On January 22, 2024, Thomas W. Ohrt was appointed the Company’s Chief Financial Officer.
Role change
(interim)
Judith S. Miller
member of the Board, Chief Business Officer, and Interim Chief Financial Officer
Judith S. Miller resigned as the Company’s Interim Chief Executive Officer and was appointed as a member of the Company’s Board of Directors (the “ Board ”), as the Chief Business Officer of the Company, and as the Interim Chief Financial Officer of the Company
Ms. Austin will retain her positions as Chief Executive Officer of the Bank and as President and Chief Executive Officer of the Company until her retirement at year-end 2024.
promoted Jason Vlacich, the Chief Accounting Officer of the Company, to the role of Chief Financial Officer and Chief Accounting Officer, effective as of January 23, 2024
The Amendment amended the Employment Agreement to reflect, among other things, the following changes: a) In Section 1.1, of the Employment Agreement, reference to Employee’s role as President was stricken.
On January 22, 2024, SIGA Technologies, Inc. (the “Company”) announced the appointment of Diem Nguyen, Ph.D., MBA, as Chief Executive Officer of the Company and a member of the Company’s Board of Directors, in each case, effective as of January 27, 2024
the Board appointed Scott A. Kingsley President and Chief Executive Officer of the Company, effective May 21, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.